ArticleUlusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES2024
The effect of intraperitoneal LR-PRP on bacterial translocation in an experimental model of peritonitis in rats.
Article in Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to examine the effect of Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) on bacterial translocation in an experimental peritonitis model in rats. Secondary peritonitis occurs due to the loss of integrity in the mucosal barrier of the gastrointestinal system, resulting from contamination of the peritoneal cavity by microorganisms. LR-PRP has been shown to have positive anti-infectious, immunomodulatory, and angiogenetic effects.
methodsTwenty-seven Wistar-Albino rats were divided into three groups: Sham, Control, and Experimental. Laparotomy was performed on the rats under anesthesia, and the cecum was isolated. No procedure was performed on the Sham group. The cecums of the rats in the Control and Experimental groups were punctured twice within 5 minutes using an 18-gauge needle. The blood product of each rat in the Experimental group was prepared for autologous use as LR-PRP and administered intraperitoneally. The abdomens of rats in all groups were closed after 8 minutes. After 8 hours, the rats were sacrificed, and tissue and blood samples were collected. Inflammatory parameters (TNF-α, IL-1, and IL-6) and blood cultures were analyzed from the blood samples. Cultures were also performed on liver, spleen, and mesenteric lymph node tissue samples.
resultsLiver tissue culture growth was not detected in rats in the sham group. It was detected in 6 rats in the control group, and in 1 rat in the experimental group. Mesenteric lymph node tissue culture growth was detected in 2 rats in the sham group, in 7 in the control group and in 1 in the experimental group. Blood culture growth was not detected in rats in the sham group, but detected in 8 rats in the control group, and 3 in the experimental group. In terms of liver tissue culture, mesenteric lymph node tissue culture, and blood culture; a significant relationship was statistically observed between the control and experimental groups (p=0.049, p=0.008, p=0.015, respectively). It was infered that a statistically significant relationship in the mean TNF-alpha, IL-1, IL-6 values was not seen between the control and experimental groups (p=0.999, p=0.999, p=0.590, respectively).
conclusionLR-PRP's ability to suppress bacterial translocation was statistically significant in liver tissue culture, mesenteric lymph node tissue culture, and blood culture when comparing the Control and Experimental groups. LR-PRP was found to be effective in preventing bacterial translocation without suppressing inflammation and exhibited antimicrobial properties as supported by the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.